European Medical Affairs & KOL Best Practices Summit

The European Medical Affairs & KOL Best Practices Summit will educate pharmaceutical, medical device, and biotechnology companies how medical affairs capabilities are currently being deployed at leading pharmaceutical companies. The agenda focuses around the theme of communicating complex scientific information in a compelling manor to the key stake-holders within the healthcare community.

With shared perspectives from 10 different pharmaceutical companies on 16 different and unique sessions, along with 8 networking breaks, the Medical Affairs & KOL Best Practices Summit will ensure that you gain new contacts, tangible ideas and best practices easily implementable at your organization.

Top Five Reasons To Attend This Conference

1. Demonstrating medical affairs value and identifying the purpose of this role
2. Hearing best practices for identifying and communicating with KOLs
3. Specifying clear boundaries for promotional scientific exchange between medical affairs and sales and marketing
4. Identifying the future for KOLs and how the relationship between KOLs and the industry may evolve as KOLs broaden their impact
5. Discovering best practices when implementing a medical affairs team or executive into an organization

Testimonials:

“Great Discussions”

- Philippe Fonjallaz, Medical Affairs, Merck Serono

“Excellent presentations”

- Kathi Cullari,CEO, Cullari Communications

“Great content, and visuals”

- MSL, H. Lundbeck A/S

“Simple but clear, effective & overall structured talk. Effective & useful”

- Expert Strategy Manager, Oncology, GlaxoSmithKline

“Speakers handled objectives well. Very open & candid, created great responses”

- MSL, Actelion